Motoaki Saito

ORCID: 0000-0001-6764-8459 · 6 papers in corpus · active 1984-2023

Study types

  • article 3
  • other 3

Condition tags

  • endometriosis 5
  • adenomyosis 1
other 2023
Gynecology and minimally invasive therapy ·doi:10.4103/gmit.gmit_44_22

OBJECTIVES: Although atypical endometrial hyperplasia (AEH) is considered a precancerous disease, the frequency with which AEH and endometrial cancer (EC) coexist is not low. Broadly, total laparoscopic hysterectomy (TLH) is performed for t…

other 2018
Oncotarget ·doi:10.18632/oncotarget.24555

Ovarian clear cell carcinoma (OCCC) exhibits distinct phenotypes, such as resistance to chemotherapy, poor prognosis and an association with endometriosis. Biomarkers and imaging techniques currently in use are not sufficient for reliable d…

article 2017
International cancer conference journal ·doi:10.1007/s13691-017-0295-9
other 2014
BMC cancer ·doi:10.1186/1471-2407-14-799

BACKGROUND: Epithelial ovarian cancer (EOC) is the most common cause of gynecological malignancy-related mortality. Ovarian clear cell carcinoma (CCC) has unique clinical characteristics and behaviors that differ from other histological typ…

article 2007
Oncology reports ·doi:10.3892/or.17.6.1333

We previously reported that indoleamine-2,3-dioxygenase (IDO) is associated with paclitaxel resistance and that IDO serves as a marker of poor prognosis in ovarian serous adenocarcinomas (SA). In this study, to explore the role of IDO in th…

article 1984